新疆交建(002941.SZ):擬0元轉讓交建暢拓51%股權
格隆匯9月22日丨新疆交建(002941.SZ)公佈,公司擬與百舸貿易簽署《股權轉讓協議》。公司擬將尚未開展業務的控股子公司新疆交建暢拓工程諮詢有限公司(簡稱“交建暢拓”)全部股權,股權比例為51%的股權以0元的價格出售給百舸貿易。該次交易完成後,公司將不再持有交建暢拓股權,公司合併報表的範圍將發生變化。
公司表示,該次出售交建暢拓51%股權,是為了進一步梳理公司下屬子公司的定位及業務關係,精簡公司組織結構、降低管理成本,聚焦主營業務板塊,提升公司資產管理效率及整體經營效益,優化公司業務結構。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.